Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine

NCT04064879 is registered in ClinicalTrials.gov with Neurological Associates of West Los Angeles as lead sponsor.

NCT NCT04064879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04064879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine
Lead sponsor
Neurological Associates of West Los Angeles
Phase
Not applicable
Overall status
Suspended
Start date
August 16, 2018
Completion date
August 16, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine, headache